Navigation Links
MabThera Significantly Extends Survival And Cures More Patients,With Aggressive Lymphoma Than Chemotherapy Alone

nts with aggressive NHL," said William M. Burns, CEO Division Roche Pharma. "Seven years after the GELA trial, over half of the MabThera patients are still alive, offering hope of a cure for thousands more."

Non-Hodgkin's lymphoma (NHL) affects 1 million people worldwide. It is estimated that 360,000 people die each year from the disease (2). Approximately 40% of NHL patients present with an aggressive form of the disease, which, if left untreated, is generally fatal within six months.

About the study The study was conducted at 86 centers in France, Belgium, and Switzerland. A total of 398 patients were enrolled between July 1998 and March 2000. Previously untreated patients with diffuse large-B-cell lymphoma, 60 to 80 years old, were randomly assigned to receive either eight cycles of CHOP every three weeks (197 patients) or eight cycles of CHOP plus rituximab given on day 1 of each cycle (202 patients). The primary end point in this study was event-free survival.

About MabThera MabThera is a therapeutic antibody that binds to a particular protein - the CD20 antigen - on the surface of normal and malignant B-cells. It then recruits the body's natural defences to attack and kill the marked B-cells. Stem cells (B-cell progenitors) in bone marrow lack the CD20 antigen, allowing healthy B-cells to regenerate after treatment and return to normal levels within several months.

MabThera is indicated for the treatment of indolent and aggressive Non-Hodgkin's Lymphoma. MabThera is known as Rituxan in the United States, Japan and Canada. To date, patients have received more than 1 million treatments with MabThera worldwide.

Genentech and Biogen Idec co-market MabThera in the United States, and Roche markets MabThera in the rest of the world, except Japan, where MabThera is co-marketed by Chugai and Zenyaku Kogyo Co. Ltd.

About Roche Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare gr
'"/>




Page: 1 2 3 4

Related medicine technology :

1. Innovative Cancer Drug MabThera Again Shown To Improve Survival Rates In Patients With Lymphoma
2. MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen
3. Arterial Plaque Significantly Reduced in Women Age 50-59 Taking Hormones, Says New Analysis of Womens Health Initiative Data
4. Prexige Study Shows Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
5. Lumiracoxib Study Showed Significantly Less Impact on Blood Pressure Than Ibuprofen in Osteoarthritis Patients with Controlled Hypertension
6. Actemra (tocilizumab) Significantly Improves Symptoms of Rheumatoid Arthritis Compared to a Current Standard of Care
7. Next Safety, Inc.s Innovative Drug Delivery System Will Replace Cigarettes and Significantly Advance Pulmonary Medication Delivery
8. Ivivis PEMF Technology Significantly Improves Neuron Survival in Parkinsons Disease Model, Study Finds
9. Mercks Investigational Migraine Treatment MK-0974 Significantly Improved Migraine Pain on Several Efficacy Measures in a Phase II Study
10. The Eloxatin-Based Regimen (FOLFOX4) Significantly Improved Progression Free Survival When Given Before and After Surgery in Patients With Resectable Liver Metastases From Colorectal Cancer
11. Nexavar Significantly Extends Overall Survival by 44% in Liver Cancer Patients

Post Your Comments:
(Date:11/19/2009)...ARK, Ill., Nov. 19 The ... as one of its Most Admired Corporate Dealmakers f...d Abbott as its Most Admired Dealmaker in pharma/b...uisitions and divestitures since January 2006. ,...usiness portfolio with a focus on high-growth, inn...
(Date:11/19/2009)...of International Internet Week of Action ,, SI...-- The U.S. Food and Drug Administration today com...rt, called the International Internet Week of Acti...ing medical products. ,, (Logo: http://www.new...ing the effort, the FDA,s Office of Criminal Inves...
(Date:11/19/2009)...ON, N.J., Nov. 19 Impliant, Inc., ...o traditional spinal fusion surgery, announced tod...anagement team as the Vice President of Clinical a...w.newscom.com/cgi-bin/prnh/20080527/NETU060LOGO ...regulatory experience in the spinal and medical de...
Breaking Medicine Technology:The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3UPDATE: FDA Issues 22 Warning Letters to Web site Operators 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 2Impliant Announces the Addition of Vice President of Clinical and Regulatory Affairs to Executive Management Team 3Mobile MedCheck Brings Back House Calls 54959 1Mobile MedCheck Brings Back House Calls 54959 2Mobile MedCheck Brings Back House Calls 54959 3Mobile MedCheck Brings Back House Calls 54959 4Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 1Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 2Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 3Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 4Angiotech Pharmaceuticals announces the commercial launch of the Option 28TM 29 Inferior Vena Cava Filter in the United States 13637 5Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 1Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 2Impax Pharmaceuticals Selects OmniComm Systems to Provide eClinical Solutions for International Phase III Study in Parkinsons Disease 4874 3
...ree Oritavancin Studies Presented at ECCMID/ICC, M...ganta,Therapeutics today announced results from tw...cin to stop bacterial growth in vitro,when tested ...ne,study demonstrating the activity of oritavancin...ia. Oritavancin, a novel,lipoglycopeptide antibiot...
...istorical Analyses Help Plan for Future Pandemics ...tent riddles of the,deadly 1918 Spanish influenza ...rying severity. Why were some municipalities such ...s like Philadelphia,when both implemented similar ...according to two independent studies funded by the...
Other Medicine Technology:Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 2Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 3Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 4Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 5Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 6Rapid Response was Crucial to Containing the 1918 Flu Pandemic 2Rapid Response was Crucial to Containing the 1918 Flu Pandemic 3Rapid Response was Crucial to Containing the 1918 Flu Pandemic 4Rapid Response was Crucial to Containing the 1918 Flu Pandemic 5
(Date:11/22/2009)... keep eating under control, expert says , ...y season means you,ll be faced with a seemingly en... simply give in and eat too much, others deny them... to navigate between overindulgence and deprivatio...n Consult Services at Brigham and Women,s Hospital...
(Date:11/22/2009)... The holiday season is filled with get-togethers...oyous. It can also be stressful and tiring at time...fatigue, and high fat foods -- factors that can, o... the National Foundation for Cancer Research has d...ensure a happier, more healthful holiday season, a...
(Date:11/22/2009)...ov. 21 Congressman Chak...n the United States Senate,s vote tonight to proce...: ,, "Senators Arlen Specter and Bob Casey dese...nians for casting stand-up, critical votes in the ...c Affordable Health Care Reform legislation to ful...
(Date:11/21/2009)... Nov. 21 DNC Chairman T...Senate voted to begin full debate of health insura...newscom.com/cgi-bin/prnh/20080519/DNCLOGO ) ,... the road to enacting health insurance reform. By ...ll now have an opportunity to debate the health re...
(Date:11/21/2009)...ov. 21 Milvia Lopez, by her attorn...ntly filed suit, in Supreme Court, New York County...es that while Ms. Lopez underwent a routine transe... HOSPITAL , doctors used an HIV infected scope exp...at several hours after being discharged from the p...
Breaking Medicine News(10 mins):Health News:Go Healthy, Not Hungry for Holiday Eating 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 2Health News:Top 10 Food Tips for the Holidays from the National Foundation for Cancer Research 3Health News:Democratic National Committee Chairman Tim Kaine's Statement on the Senate's Vote to Proceed to Full Floor Debate of Health Insurance Reform Legislation 2Health News:Patient Files Suit Against St. Vincent's Hospital in New York City as a Result of the Alleged Use by the Hospital of an HIV Infected Device During a Routine Procedure 2
...ks of the,holidays are upon us, everyone wants to ...r, veteran stylist and owner of The Fisher Experie... there are several things you,should remember when...d friends at home, everyone wants to look,their be...
...ren,s Center scientists has figured out why a resp...oculate children against the infection instead cau...pped efforts to make a better one. The findings, p... researchers say. The new findings also debunk a p...
...tement , , VIRGINIA BEACH, Va., Dec. 15, 2008...today that it filed a universal shelf registration...hange Commission on December 15, 2008. The registr...nd on terms to be determined at the time of the ap...
...Food,and Drug Administration (FDA) approved Abbott...capsules for use along with diet to help lower tri...holesterol in patients with lipid,problems. TRILI...ation of a fibrate with a statin to further improv...
...plications, experts say , , MONDAY, Dec. 1...ealth insurance are more like to fare poorly after...ntestinal condition known as diverticulitis, a new...earchers say. , "Uninsured patients are more likel...
...h School Student Volunteers Collaborate in Musical... N.J., Dec. 15 Sharing The Arts, a Hawthorne, ...nd conservatory bringing together individuals with...needs are performing in its production of "Charli...
Other Medicine News:Health News:Just in Time for the Holiday Rush, Braintree Stylist Bruce Fisher Offers Holiday Style & Beauty Tips 2Health News:Hopkins-led team solves failed vaccine mystery 2Health News:AMERIGROUP Files Shelf Registration Statement 2Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 2Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 3Health News:Abbott Receives FDA Approval for TRILIPIX(TM) (fenofibric acid), First and Only Fibrate Indicated for Use in Combination With a Statin for Cholesterol Management 4Health News:Uninsured Face Worse Outcomes After Diverticulitis 2Health News:Uninsured Face Worse Outcomes After Diverticulitis 3Health News:Sharing The Arts & Ridgewood High School Present Musical Production of Charlie and The Chocolate Factory 2
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
... ARUP Laboratories is a national reference laborat...y research and development. ARUP offers an extensi...tests in clinical and anatomic pathology. Owned by...s include more than half of the nation's universit...
Medicine Products: